Screener
Staar Surgical STAA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Staar Surgical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Staar Surgical’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0000718937-26-000037
| Line item | Three Months Ended / July 3, 2026 | Three Months Ended / June 27, 2025 | Six Months Ended / July 3, 2026 | Six Months Ended / June 27, 2025 |
|---|---|---|---|---|
| Provision (benefit) for income taxes | 2,966 | (9,103) | 5,978 | (9,378) |
| Net income (loss) | $8,058 | $(16,812) | $13,264 | $(71,023) |
| Net income (loss) per share: | ||||
| Basic | $0.16 | $(0.34) | $0.26 | $(1.44) |
| Diluted | $0.16 | $(0.34) | $0.26 | $(1.44) |
| Weighted average shares outstanding: | ||||
| Basic | 50,321 | 49,520 | 50,114 | 49,432 |
| Diluted | 51,501 | 49,520 | 51,293 | 49,432 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Staar Surgical's EPS (diluted)?
- Staar Surgical (STAA) reported EPS (diluted) of $0.16 in Q2 2026.
- How has Staar Surgical's EPS (diluted) changed year-over-year?
- Staar Surgical's EPS (diluted) increased by 147.1% year-over-year, from -$0.34 to $0.16.
- What is the long-term trend for Staar Surgical's EPS (diluted)?
- Over 4 years (2021 to 2025), Staar Surgical's EPS (diluted) has grown at a 34.8% compound annual growth rate (CAGR), from $0.49 to -$1.62.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Staar Surgical's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude